Royal Gold Investing Cash Flow increased by 113.0% to $34.11M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 158.5%, from -$58.30M to $34.11M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a 15.4% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$107.20M | -$272.73M | -$37.81M | -$66.00K | -$678.63M | -$206.37M | -$197.00K | -$2.62M | -$6.00K | -$2.00K | $23.59M | -$50.93M | -$3.43M | -$46.91M | -$58.30M | -$112.75M | -$985.91M | -$261.60M | $34.11M |
| QoQ Change | — | -154.4% | +86.1% | +99.8% | <-999% | +69.6% | +99.9% | <-999% | +99.8% | +66.7% | >999% | -315.9% | +93.3% | <-999% | -24.3% | -93.4% | -774.4% | +73.5% | +113.0% |
| YoY Change | — | — | — | +99.9% | -148.8% | — | +99.5% | <-999% | +100.0% | +100.0% | >999% | <-999% | <-999% | <-999% | -347.1% | -121.4% | <-999% | -457.7% | +158.5% |